glp 1 intracranial hypertension GLP-1 Receptor Agonists Significantly Improve Effects of Idiopathic Metabolic Concepts in Idiopathic Intracranial...

But what do we really know about them so far, and where might the future lead

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a naturally occurring protein found in gastric juice, studied as one of the most versatile and extensively researched regenerative peptides in pre-clinical science with a research profile spanning gut biology, tendon and ligament repair, angiogenesis, muscle tissue, neurological function, and wound healing models

BPC-157 has over 100 preclinical studies documenting VEGFR2 activation and Akt-eNOS signaling (DOI: 10.1007/s00109-016-1488-y)

A key differential side effect for Retatrutide is a transient, dose-dependent increase in heart rate observed in the clinical trials, which necessitates careful cardiac screening and monitoring by a supervising physician

The odds ratio of fused myonuclei for control are 0.58 and 0.53 times the odds at the low and high NNMTi dose, respectively.NNMTi (subcutaneous injection